Skip to main content

LB Pharmaceuticals Inc

LBRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001691082

No open-market purchases or sales by LB Pharmaceuticals Inc insiders were filed in the last 90 days; 114 institutions reported holding it in 13F filings for Q2 2026, worth $965.9M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding LB Pharmaceuticals Inc changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of LBRX: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders053+53
Shares019.9M+19.9M
Value$0$314.9M+$314.9M

New holders (53)

Institutions that held LB Pharmaceuticals Inc at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to LBRX in Q3 2025
InstitutionSharesValue% of portfolio
Deep Track Capital, LP3,352,804$52.9M1.48%
Ra Capital Management, L.P.1,776,958$28.1M0.35%
TCG Crossover Management, LLC1,745,016$27.6M1.36%
Commodore Capital LP1,500,000$23.7M1.16%
Logos Global Management LP1,130,000$17.8M1.76%
JPMorgan Chase & Co1,032,603$16.3M0.00%
BlackRock, Inc.975,000$15.4M0.00%
Balyasny Asset Management LLC968,274$15.3M0.03%
Vivo Capital, LLC800,000$12.6M1.02%
Jennison Associates LLC739,040$11.7M0.01%
Alyeska Investment Group, L.P.675,000$10.7M0.03%
Nantahala Capital Management, LLC675,000$10.7M0.66%
Citadel Advisors LLC539,370$8.52M0.01%
Millennium Management LLC538,169$8.50M0.01%
Soleus Capital Management, L.P.400,000$6.32M0.34%
FMR LLC369,100$5.83M0.00%
Wellington Management Group LLP344,657$5.44M0.00%
Goldman Sachs Group Inc343,523$5.42M0.00%
Nan Fung Group Holdings Ltd300,000$4.74M7.95%
Price T Rowe Associates Inc282,644$4.46M0.00%
Marshall Wace, LLP255,526$4.03M0.00%
Adage Capital Partners GP, L.L.C.200,000$3.16M0.01%
Baker Bros. Advisors LP200,000$3.16M0.02%
Integral Health Asset Management, LLC100,000$1.58M0.12%
Ameriprise Financial Inc77,450$1.22M0.00%
Silverarc Capital Management, LLC70,000$1.11M0.16%
Boxer Capital Management, LLC70,000$1.11M0.35%
HRT Financial LP58,815$928.0K0.00%
Monashee Investment Management LLC40,000$631.6K0.31%
TD Asset Management Inc36,780$580.8K0.00%
Point72 (DIFC) Ltd34,003$536.9K0.04%
Barclays PLC30,839$486.9K0.00%
Jane Street Group, LLC30,345$479.1K0.00%
Acuta Capital Partners, LLC30,000$473.7K0.49%
Hudson Bay Capital Management LP27,097$427.9K0.00%
Squarepoint Ops LLC20,825$328.8K0.00%
Oxford Asset Management LLP17,763$280.5K0.09%
Manufacturers Life Insurance Company, The17,488$276.1K0.00%
Aristeia Capital LLC15,270$241.1K0.01%
Point72 Asia (Singapore) Pte. Ltd.14,535$229.5K0.04%
Quantessence Capital LLC14,225$224.6K0.07%
Geode Capital Management, LLC13,591$214.6K0.00%
Two Sigma Investments, LP13,500$213.2K0.00%
Brevan Howard Capital Management LP13,259$209.4K0.00%
Jefferies Financial Group Inc.13,100$206.8K0.00%
XTX Topco Ltd11,276$178.0K0.01%
Landscape Capital Management, L.L.C.10,638$168.0K0.01%
Morgan Stanley9,605$151.7K0.00%
Federated Hermes, Inc.9,000$142.1K0.00%
Bank of America Corp1,700$26.8K0.00%
UBS Group AG1,055$16.7K0.00%
Wells Fargo & Company1,000$15.8K0.00%
Quarry LP11$1740.00%

Sold out (0)

Institutions that held LB Pharmaceuticals Inc at the end of Q2 2025 and filed for Q3 2025 without it.

None.